Patients enrolled
|
11457
|
Gender (11345)
|
|
Male
|
5836 (51%)
|
Female
|
5509 (49%)
|
Median age (range), years
|
67 (7 – 100)
|
Age groups (10886)
|
|
< 20
|
21 (0.2%)
|
20 – 29
|
115 (1.1%)
|
30 – 39
|
235 (2.2%)
|
40 – 49
|
829 (7.6%)
|
50 – 59
|
1879 (17.3%)
|
60 – 69
|
3083 (28.3%)
|
70 – 79
|
3183 (29.2%)
|
≥ 80
|
1541 (14.2%)
|
Median weight (pounds)
|
170
|
Median height (inches)
|
67
|
Median Karnofsky score (range)
|
90 (10–100)
|
Race/ethnicity (10352)
|
|
Caucasian
|
9269 (89.5%)
|
Black/African American
|
682 (6.6%)
|
Hispanic
|
185 (1.8%)
|
Asian
|
83 (0.8%)
|
Pacific-Asian Islander
|
13 (0.1%)
|
Other
|
51 (0.5%)
|
Don’t know
|
69 (0.7%)
|
Primary health insurance (10547)
|
|
Private
|
40%
|
Medicare
|
54.4%
|
Self-pay/none
|
0.7%
|
Patients not treated with SRS/SBRT
|
1060 (9%)
|
Reason for not completing SRS/SBRT (1060)
|
|
SRS/SBRT determined not clinically appropriate after further review
|
272 (25.7%)
|
Patient has extensive disease
|
226 (21.3%)
|
Patient declined SRS/SBRT
|
148 (14.0%)
|
Watchful waiting indicated
|
109 (10.3%)
|
Payment not pre-authorized
|
53 (5.0%)
|
Alternative insurance-covered treatment elected
|
44 (4.2%)
|
Other
|
29 (2.7%)
|
Patient not able to tolerate SRS/SBRT
|
16 (1.5%)
|
Co-morbidities rule out SRS/SBRT |
15 (1.4%) |